Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 25 clinical trials
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer

Participating in the program may improve knowledge and confidence about follow-up care, communication with cancer care and primary care doctors, and quality of life after cancer treatment in non-small cell lung cancer or colorectal cancer survivors.

stage ii colorectal cancer ajcc v8
stage ia2 lung cancer ajcc v8
stage iia colorectal cancer ajcc v8
stage iii colorectal cancer ajcc v8
stage iia lung cancer ajcc v8
  • 4 views
  • 19 Feb, 2024
  • 1 location
Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.

The objective of this trial is to study the efficacy of treatment of human papilloma virus (HPV) related oropharyngeal cancer with chemotherapy followed by Transoral Robotic Surgery (TORS) as definitive treatment. Current treatment of oropharyngeal cancer are chemo-radiotherapy. There is significant lifelong side effects associated with this approach related to …

papilloma
human papillomavirus
neck dissection
docetaxel
oropharyngeal
  • 0 views
  • 19 Feb, 2024
  • 1 location
Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy

This study is for verification of predictive biomarkers for pancreatic cancer treatment using multi-center liquid biopsy.

pancreatic cancer
pancreatic adenocarcinoma
adenocarcinoma
cancer
cancer treatment
  • 0 views
  • 19 Feb, 2024
  • 1 location
Excess Risk of Morbi-mortality Due to COVID-19 in Patients With Cancer

For example, the experts were uncomfortable to formulate precise guidelines on which anti-cancer treatment should be interrupted or replaced, on which patients, and how to adapt supportive drug prescriptions. Objectives : To measure the excess risk of mortality and morbidity of patients with a history of cancer among patients hospitalized …

  • 0 views
  • 19 Feb, 2024
  • 5 locations
Guardant360 Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer

The purpose of this study is to observe the routine clinical care of patients who have been diagnosed with breast cancer and have undergone Guardant360 testing.

cancer
breast cancer
  • 0 views
  • 19 Feb, 2024
  • 1 location
Innovating Access to Novel Therapies Through Standardized Prospective Integration of Response Evaluations (IMPACT-INSPIRE) (IMPACT-INSPIRE)

This observational study aims to assess the outcomes in patients with advanced treatment refractory cancers with matched molecular/precision therapy as per their molecular profiling results after discussion at molecular tumour board.To standardize response assessment and data collection for patients that are receiving off-label or non-standard therapies based on MTB recommendations.- …

  • 0 views
  • 07 May, 2025
NCI COVID-19 in Cancer Patients NCCAPS Study

Collecting blood samples, medical information, and medical images may help researchers determine how COVID-19 affects the outcomes of patients undergoing cancer treatment and how having cancer affects COVID-19.

pertuzumab
antibody test
stem cell transplant
rituximab
solid tumor
  • 0 views
  • 19 Feb, 2024
  • 576 locations
COVID-19 and Cancer Patients

Routinely collected data will be used to assess the morbidity and mortality of cancer patients following a positive COVID-19 infection.

SARS
acute respiratory syndrome (sars)
cancer
covid-19
  • 0 views
  • 19 Feb, 2024
  • 1 location
Cancer Therapy Effects on the Heart

Anthracycline chemotherapies (e.g. doxorubicin, daunorubicin) is commonly given to treat pediatric cancer, and carries a risk of cardiotoxicity. Over the long term, children who receive these therapies have an increased risk of heart failure and early cardiovascular death. However, current strategies for identifying patients who are at risk prior to …

pediatric cancer
doxorubicin
electrocardiogram
anthracyclines
anthracycline
  • 0 views
  • 19 Feb, 2024
  • 1 location
Immunotherapy in Lung Cancer: Treatment After IO Cessation.

Immunotherapy is now a standard of care for first-line and eventually salvage therapy in patients with stage IV NSCLC and as adjuvant after RT-CT for stage III NSCLC. The aim of the study is determining the therapeutic landscape and the reason for immunotherapy cessation.

carcinoma of the cervix
adjuvant
stage iii non-small cell lung cancer
stage iv non-small cell lung cancer
small cell lung cancer
  • 0 views
  • 19 Feb, 2024
  • 5 locations